<VariationArchive VariationID="1726239" VariationName="NM_000182.5(HADHA):c.1432del (p.Ala478fs)" VariationType="Deletion" Accession="VCV001726239" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-17" DateCreated="2022-11-19" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1783766" VariationID="1726239">
      <GeneList>
        <Gene Symbol="GAREM2" FullName="GRB2 associated regulator of MAPK1 subtype 2" GeneID="150946" HGNC_ID="HGNC:27172" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="26173088" stop="26204304" display_start="26173088" display_stop="26204304" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="26395959" stop="26412531" display_start="26395959" display_stop="26412531" Strand="+" />
          </Location>
          <OMIM>617999</OMIM>
        </Gene>
        <Gene Symbol="HADHA" FullName="hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha" GeneID="3030" HGNC_ID="HGNC:4801" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="26190635" stop="26244632" display_start="26190635" display_stop="26244632" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="26413503" stop="26467593" display_start="26413503" display_stop="26467593" Strand="-" />
          </Location>
          <OMIM>600890</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000182.5(HADHA):c.1432del (p.Ala478fs)</Name>
      <CanonicalSPDI>NC_000002.12:26197737:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="26197738" stop="26197738" display_start="26197738" display_stop="26197738" variantLength="1" positionVCF="26197737" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="26420607" stop="26420607" display_start="26420607" display_stop="26420607" variantLength="1" positionVCF="26420606" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>A478fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.26420607del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.26420607del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.26197738del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.26197738del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007121.2" sequenceAccession="NG_007121" sequenceVersion="2" change="g.51884del">
            <Expression>NG_007121.2:g.51884del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000182.5" sequenceAccession="NM_000182" sequenceVersion="5" change="c.1432del" MANESelect="true">
            <Expression>NM_000182.5:c.1432del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000173.2" sequenceAccession="NP_000173" sequenceVersion="2" change="p.Ala478fs">
            <Expression>NP_000173.2:p.Ala478fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_747" sequenceAccession="LRG_747">
            <Expression>LRG_747:g.51884del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_747t1" sequenceAccession="LRG_747t1">
            <Expression>LRG_747t1:c.1432del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_747p1" sequenceAccession="LRG_747p1" change="p.Ala478fs">
            <Expression>LRG_747p1:p.Ala478fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000182.5(HADHA):c.1432del (p.Ala478fs) AND multiple conditions" Accession="RCV002307210" Version="4">
        <ClassifiedConditionList TraitSetID="39862">
          <ClassifiedCondition DB="MedGen" ID="C3711645">Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1969443">Mitochondrial trifunctional protein deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-05-30" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000182.5(HADHA):c.1432del (p.Ala478fs) AND Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency" Accession="RCV004572233" Version="1">
        <ClassifiedConditionList TraitSetID="6645">
          <ClassifiedCondition DB="MedGen" ID="C3711645">Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-09" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2022-11-19" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21103935</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21549624</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22459206</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7738175</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="39862" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9419" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Mitochondrial trifunctional protein deficiency</ElementValue>
                <XRef ID="MONDO:0012172" DB="MONDO" />
                <XRef ID="237999008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">TFP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Long-chain hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and trifunctional protein (TFP) deficiency are caused by impairment of mitochondrial TFP. TFP has three enzymatic activities – long-chain enoyl-CoA hydratase, long-chain 3-hydroxyacyl-CoA dehydrogenase, and long-chain 3-ketoacyl-CoA thiolase. In individuals with LCHAD deficiency, there is isolated deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase, while deficiency of all three enzymes occurs in individuals with TFP deficiency. Individuals with TFP deficiency can present with a severe-to-mild phenotype, while individuals with LCHAD deficiency typically present with a severe-to-intermediate phenotype. Neonates with the severe phenotype present within a few days of birth with hypoglycemia, hepatomegaly, encephalopathy, and often cardiomyopathy. The intermediate phenotype is characterized by hypoketotic hypoglycemia precipitated by infection or fasting in infancy. The mild (late-onset) phenotype is characterized by myopathy and/or neuropathy. Long-term complications include peripheral neuropathy and retinopathy.</Attribute>
                <XRef ID="NBK583531" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3684" />
                <XRef ID="3684" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36063482</ID>
                <ID Source="BookShelf">NBK583531</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-OH-C18-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, LCHAD/TFP: C16-OH Elevated +/-C18-OH, 2022</CitationText>
              </Citation>
              <XRef ID="746" DB="Orphanet" />
              <XRef ID="C1969443" DB="MedGen" />
              <XRef ID="MONDO:0012172" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS609015" DB="OMIM" />
            </Trait>
            <Trait ID="15869" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="MONDO:0012173" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LCHAD Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deficiency of long-chain 3-hydroxyacyl-coenzyme A dehydrogenase</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6867" />
                <XRef ID="6867" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Long-chain hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and trifunctional protein (TFP) deficiency are caused by impairment of mitochondrial TFP. TFP has three enzymatic activities – long-chain enoyl-CoA hydratase, long-chain 3-hydroxyacyl-CoA dehydrogenase, and long-chain 3-ketoacyl-CoA thiolase. In individuals with LCHAD deficiency, there is isolated deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase, while deficiency of all three enzymes occurs in individuals with TFP deficiency. Individuals with TFP deficiency can present with a severe-to-mild phenotype, while individuals with LCHAD deficiency typically present with a severe-to-intermediate phenotype. Neonates with the severe phenotype present within a few days of birth with hypoglycemia, hepatomegaly, encephalopathy, and often cardiomyopathy. The intermediate phenotype is characterized by hypoketotic hypoglycemia precipitated by infection or fasting in infancy. The mild (late-onset) phenotype is characterized by myopathy and/or neuropathy. Long-term complications include peripheral neuropathy and retinopathy.</Attribute>
                <XRef ID="NBK583531" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36063482</ID>
                <ID Source="BookShelf">NBK583531</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-OH-C18-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, LCHAD/TFP: C16-OH Elevated +/-C18-OH, 2022</CitationText>
              </Citation>
              <XRef ID="5" DB="Orphanet" />
              <XRef ID="C3711645" DB="MedGen" />
              <XRef ID="MONDO:0012173" DB="MONDO" />
              <XRef Type="MIM" ID="609016" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6645" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15869" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="MONDO:0012173" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LCHAD Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deficiency of long-chain 3-hydroxyacyl-coenzyme A dehydrogenase</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6867" />
                <XRef ID="6867" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Long-chain hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and trifunctional protein (TFP) deficiency are caused by impairment of mitochondrial TFP. TFP has three enzymatic activities – long-chain enoyl-CoA hydratase, long-chain 3-hydroxyacyl-CoA dehydrogenase, and long-chain 3-ketoacyl-CoA thiolase. In individuals with LCHAD deficiency, there is isolated deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase, while deficiency of all three enzymes occurs in individuals with TFP deficiency. Individuals with TFP deficiency can present with a severe-to-mild phenotype, while individuals with LCHAD deficiency typically present with a severe-to-intermediate phenotype. Neonates with the severe phenotype present within a few days of birth with hypoglycemia, hepatomegaly, encephalopathy, and often cardiomyopathy. The intermediate phenotype is characterized by hypoketotic hypoglycemia precipitated by infection or fasting in infancy. The mild (late-onset) phenotype is characterized by myopathy and/or neuropathy. Long-term complications include peripheral neuropathy and retinopathy.</Attribute>
                <XRef ID="NBK583531" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36063482</ID>
                <ID Source="BookShelf">NBK583531</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C16-OH-C18-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, LCHAD/TFP: C16-OH Elevated +/-C18-OH, 2022</CitationText>
              </Citation>
              <XRef ID="5" DB="Orphanet" />
              <XRef ID="C3711645" DB="MedGen" />
              <XRef ID="MONDO:0012173" DB="MONDO" />
              <XRef Type="MIM" ID="609016" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5085540" SubmissionDate="2022-11-17" DateLastUpdated="2022-12-24" DateCreated="2022-11-19">
        <ClinVarSubmissionID localKey="13339951|OMIM:609015;OMIM:609016" />
        <ClinVarAccession Accession="SCV002604681" DateUpdated="2022-12-24" DateCreated="2022-11-19" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>NM_000182.4(HADHA):c.1432delG(A478Lfs*17) is expected to be pathogenic in the context of HADHA-related disorders. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in HADHA, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2021)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/wpe7ty9o/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2021_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HADHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="G" referenceAllele="GC" start="26420606" stop="26420607" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">13339951</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609016" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609015" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12292560</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6137987" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="5182852|MedGen:C1969443;CN074230" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003449057" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7738175</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21103935</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21549624</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22459206</ID>
          </Citation>
          <Comment>This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with HADHA-related conditions. This sequence change creates a premature translational stop signal (p.Ala478Leufs*17) in the HADHA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HADHA are known to be pathogenic (PMID: 7738175, 21103935, 21549624, 22459206).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HADHA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.26420607del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1969443" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN074230" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9819110" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_000182.5:c.1432del|OMIM:609016" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005059659" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000182.5:c.1432del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609016" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5085540" TraitType="Disease" MappingType="XRef" MappingValue="609016" MappingRef="OMIM">
        <MedGen CUI="C3711645" Name="Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9819110" TraitType="Disease" MappingType="XRef" MappingValue="609016" MappingRef="OMIM">
        <MedGen CUI="C3711645" Name="Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6137987" TraitType="Disease" MappingType="XRef" MappingValue="C1969443" MappingRef="MedGen">
        <MedGen CUI="C1969443" Name="Mitochondrial trifunctional protein deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5085540" TraitType="Disease" MappingType="XRef" MappingValue="609015" MappingRef="OMIM">
        <MedGen CUI="CN376812" Name="Mitochondrial trifunctional protein deficiency 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6137987" TraitType="Disease" MappingType="XRef" MappingValue="CN074230" MappingRef="MedGen">
        <MedGen CUI="C3711645" Name="Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

